Autologous Matrix-induced Chondrogenesis Market: By Material Type (Hyaluronic Acid, Polyethylene glycol (PEG), Collagen, Polylactic-co-glycolic Acid, Others), By Application (Knee Cartilage Repair, Elbow Cartilage Repair, Hip Cartilage Repair, Others), By End User (Hospitals, Clinics, Ambulatory Surgical Centers (ASCs)), and Geography.  

Purchase Option

$ 4400
$ 6600
$ 8900

Autologous Matrix-induced Chondrogenesis Market size was valued at 97.43 million in 2022 and is poised to grow at a CAGR of 8.6% from 2023-2029. Autologous matrix-induced chondrogenesis is a single-step cartilage restoration process that helps to repair the articular cartilage damage. In this process, the microfracture is combined with the bi-layer collagen I/III. Membrane. AMIC is developed for the treatment of osteochondral and traumatic chondral lesions to establish the first-line treatment. The AMIC slows down the cartilage degeneration to delay or avoid partial or total joint replacement surgery.

Global Autologous Matrix Induced Chondrogenesis Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

8.6%

Largest Market

Asia-Pacific

Fastest Growing Market

North-America
Autologous Matrix-induced Chondrogenesis Market Dynamics

Increase in the geriatric population more prone for bone and joint disorders is a key factor drives the global autologous matrix-induced chondrogenesis market. Moreover, rise in number of sports injuries, increase in the preference for minimally invasive surgical procedures, less post-operative complications and lower cost compared with conventional surgeries, increasing in the R&D for the advancement in AMIC, rise in disposable income, and increase in the awareness about AMIC in developed and emerging countries are anticipated to surge the global autologous matrix-induced chondrogenesis market over the forecast years. However, lack of favorable reimbursement policies and dearth of skilled professionals and clinical date are restrain the growth of autologous matrix-induced chondrogenesis market over the forecast timeframe.

Global Autologous Matrix Induced Chondrogenesis Market Segmentation

By Material Type
  • Hyaluronic Acid
  • Polyethylene glycol (PEG)
  • Collagen
  • Polylactic-co-glycolic Acid
  • Others
By Application
  • Knee Cartilage Repair
  • Elbow Cartilage Repair
  • Hip Cartilage Repair
  • Others
By End User
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers (ASCs)

Frequently Asked Questions

The autologous matrix-induced chondrogenesis market size was valued at 97.43 million in 2022

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

The autologous matrix-induced chondrogenesis market key players are Anika Therapeutics, Inc. (U.S.), Arthro-Kinetics AG (Germany), Braun Melsungen AG (Germany), BioTissue AG (Switzerland), CartiHeal (Israel), Geistlich Pharma AG (Switzerland), JRI Orthopaedics Ltd. (AK Medical) (U.K.)

Key Features of the Reports

  • The autologous matrix-induced chondrogenesis market report provides granular level information about the market size, regional market share, historic market (2018-2022), and forecast (2023-2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
1.Executive Summary
2.Global Autologous Matrix-induced Chondrogenesis Market Introduction 
2.1.Global Autologous Matrix-induced Chondrogenesis Market  - Taxonomy
2.2.Global Autologous Matrix-induced Chondrogenesis Market  - Definitions
2.2.1. By Material Type 
2.2.2. By Application
2.2.3. By End Users
2.2.4. By Region
3.Global Autologous Matrix-induced Chondrogenesis Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Autologous Matrix-induced Chondrogenesis Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Autologous Matrix-induced Chondrogenesis Market  By Material Type , 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Hyaluronic Acid
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Polyethylene glycol (PEG)
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Collagen
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Polylactic-co-glycolic Acid
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Others
5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
6.Global Autologous Matrix-induced Chondrogenesis Market  By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Knee Cartilage Repair
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Elbow Cartilage Repair
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Hip Cartilage Repair
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Others
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7.Global Autologous Matrix-induced Chondrogenesis Market  By End Users, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Clinics
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Ambulatory Surgical Centers (ASCs)
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Autologous Matrix-induced Chondrogenesis Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Autologous Matrix-induced Chondrogenesis Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. Material Type  Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Hyaluronic Acid
9.1.2.Polyethylene glycol (PEG)
9.1.3.Collagen
9.1.4.Polylactic-co-glycolic Acid
9.1.5.Others
9.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Knee Cartilage Repair
9.2.2.Elbow Cartilage Repair
9.2.3.Hip Cartilage Repair
9.2.4.Others
9.3.  End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals
9.3.2.Clinics
9.3.3.Ambulatory Surgical Centers (ASCs)
9.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Autologous Matrix-induced Chondrogenesis Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Material Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Hyaluronic Acid
10.1.2.Polyethylene glycol (PEG)
10.1.3.Collagen
10.1.4.Polylactic-co-glycolic Acid
10.1.5.Others
10.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Knee Cartilage Repair
10.2.2.Elbow Cartilage Repair
10.2.3.Hip Cartilage Repair
10.2.4.Others
10.3.  End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.Clinics
10.3.3.Ambulatory Surgical Centers (ASCs)
10.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Autologous Matrix-induced Chondrogenesis Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Material Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Hyaluronic Acid
11.1.2.Polyethylene glycol (PEG)
11.1.3.Collagen
11.1.4.Polylactic-co-glycolic Acid
11.1.5.Others
11.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Knee Cartilage Repair
11.2.2.Elbow Cartilage Repair
11.2.3.Hip Cartilage Repair
11.2.4.Others
11.3.  End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.Clinics
11.3.3.Ambulatory Surgical Centers (ASCs)
11.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Autologous Matrix-induced Chondrogenesis Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Material Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Hyaluronic Acid
12.1.2.Polyethylene glycol (PEG)
12.1.3.Collagen
12.1.4.Polylactic-co-glycolic Acid
12.1.5.Others
12.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Knee Cartilage Repair
12.2.2.Elbow Cartilage Repair
12.2.3.Hip Cartilage Repair
12.2.4.Others
12.3.  End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.Clinics
12.3.3.Ambulatory Surgical Centers (ASCs)
12.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Autologous Matrix-induced Chondrogenesis Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1. Material Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Hyaluronic Acid
13.1.2.Polyethylene glycol (PEG)
13.1.3.Collagen
13.1.4.Polylactic-co-glycolic Acid
13.1.5.Others
13.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Knee Cartilage Repair
13.2.2.Elbow Cartilage Repair
13.2.3.Hip Cartilage Repair
13.2.4.Others
13.3.  End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.Clinics
13.3.3.Ambulatory Surgical Centers (ASCs)
13.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Anika Therapeutics, Inc. (U.S.)
14.2.2.Arthro-Kinetics AG (Germany)
14.2.3.Braun Melsungen AG (Germany)
14.2.4.BioTissue AG (Switzerland)
14.2.5.CartiHeal (Israel)
14.2.6.Geistlich Pharma AG (Switzerland)
14.2.7.JRI Orthopaedics Ltd. (AK Medical) (U.K.)
14.2.8.Matricel GmbH Germany)
14.2.9.Smith & Nephew plc (U.K.)
14.2.10.Zimmer Biomet Holdings (U.S.)
15. Research Methodology 
16. Appendix and Abbreviations 
  • Anika Therapeutics, Inc. (U.S.)
  • Arthro-Kinetics AG (Germany)
  • Braun Melsungen AG (Germany)
  • BioTissue AG (Switzerland)
  • CartiHeal (Israel)
  • Geistlich Pharma AG (Switzerland)
  • JRI Orthopaedics Ltd. (AK Medical) (U.K.)
  • Matricel GmbH Germany)
  • Smith & Nephew plc (U.K.)
  • Zimmer Biomet Holdings (U.S.)

Adjacent Markets